Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.13% | 17.68% | -11.40% | 36.67% | -21.41% |
| Total Depreciation and Amortization | 126,480.00% | -99.65% | 28,810.00% | 200.00% | -200.00% |
| Total Amortization of Deferred Charges | -198.11% | 4,536.69% | -23.63% | -22.22% | 260.00% |
| Total Other Non-Cash Items | 211.65% | -105.21% | 368.42% | 181.11% | -134.93% |
| Change in Net Operating Assets | 318.44% | -258.54% | 217.31% | -187.00% | 794.83% |
| Cash from Operations | 76.52% | -148.44% | 62.96% | 21.71% | -32.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -200.00% | -- | -- | -- |
| Cash from Investing | -14,990.56% | 98.82% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -3.00% | -3.09% |
| Issuance of Common Stock | -- | 54.54% | 1,132,300.00% | -99.99% | -34.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 194.57% | -6,862.79% | 113.78% | 42.33% | 90.18% |
| Cash from Financing | 55.82% | 41.43% | 2,453.84% | -102.63% | -28.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.25% | 142.93% | 35.34% | -992.49% | -88.23% |